Low-Dose vs. Standard-Dose Nintedanib at Initiation in Fibrosing ILD: A Target-Trial Emulation of Treatment Persistence and Lung Function
{{output}}
Rationale: Early intolerance to nintedanib may shorten time spent on treatment. Whether initiating treatment at 100 mg vs. 150 mg twice daily improves treatment persistence for 12 months without compromising lung function is unce... ...
